FluMist Intranasal Vaccine (Influenza Live Attenuated, Trivalent) CAIV-T
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FluMist Intranasal Vaccine (Influenza Live Attenuated, Trivalent) CAIV-T, covering 2012-03-06 to 2012-03-06. Get the full timeline:
Most recent: Clinical Trial Update: Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A and B, Live Cold-adapted (CAIV-T) in Healthy Children [Phase 2]